HSOA — Encompass Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Encompass Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	4,015	4,349	4,801	5,373	5,935
Cost of Revenue
Gross Profit	3,831	4,147	4,583	5,134	5,681
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,357	3,720	4,069	4,509	4,882
Operating Profit	658	629	732	864	1,053
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	505	451	607	750	953
Provision for Income Taxes
Net Income After Taxes	403	351	475	599	760
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	412	271	352	456	566
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	412	270	350	453	565
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.01	2.6	3.65	4.54	5.56
Dividends per Share